tiprankstipranks
Trending News
More News >
Royalty Pharma PLC (RPRX)
NASDAQ:RPRX

Compare Royalty Pharma (RPRX) vs. Competitors

Compare
1,297 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Royalty Pharma
$40.26
$23.89B
23.02
53.66%
3 Buy
0 Hold
0 Sell
Strong Buy
Incyte
$105.92
$21.71B
17.77
44.84%
9 Buy
9 Hold
1 Sell
Moderate Buy
United Therapeutics
$490.83
$21.69B
18.60
33.88%
5 Buy
3 Hold
0 Sell
Moderate Buy
Ascendis Pharma
$208.75
$13.03B
-49.15
55.29%
13 Buy
0 Hold
0 Sell
Strong Buy
Genmab
$33.63
$20.80B
14.17
51.55%
5 Buy
2 Hold
0 Sell
Moderate Buy
BioNTech SE
$98.85
$24.06B
-37.57
-19.07%
12 Buy
3 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
RPRX
Royalty Pharma
40.26
11.50
39.99%
INCY
Incyte
105.92
35.38
50.16%
UTHR
United Therapeutics
490.83
125.86
34.49%
ASND
Ascendis Pharma
208.75
79.56
61.58%
GMAB
Genmab
33.63
11.48
51.83%
BNTX
BioNTech SE
98.85
-24.00
-19.54%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts